The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pulmonary edema, noncardiogenic (NCPE)
Publications
Noncardiogenic pulmonary edema triggered by acetazolamide, a rare complication of acetazolamide challenge test.
Journal of cerebrovascular and endovascular neurosurgery. 2026
Acetazolamide-induced pulmonary oedema: A disproportionality analysis from the EudraVigilance database.
British journal of clinical pharmacology. 2024;90(7):1751-1755
Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event.
American journal of ophthalmology case reports. 2023;30:101827
A case of non-cardiogenic pulmonary edema provoked by intravenous acetazolamide.
Acute medicine & surgery. 2017;4(3):349-352
Acute pulmonary oedema due to single dose acetazolamide taken after cataract surgery.
BMJ case reports. 2016;2016
Recurrent shock and pulmonary edema due to acetazolamide medication after cataract surgery.
Heart & lung : the journal of critical care. 2014;43(2):124-6
Acute pulmonary edema after a single oral dose of acetazolamide.
Hippokratia. 2013;17(2):177-9
Anaphylactic shock and acute pulmonary edema after a single oral dose of acetazolamide.
The American journal of emergency medicine. 2002;20(4):371-2